• AKTIP as a Biomarker for Fibrolamellar Carcinoma: WGCNA and

  2026-08-01

  This study identifies AKTIP as a robust diagnostic and prognostic biomarker for fibrolamellar carcinoma (FLC) using integrated weighted gene co-expression network analysis (WGCNA) and machine learning. The work provides evidence for AKTIP's clinical relevance and proposes new avenues for targeted therapeutic strategies in this rare liver cancer subtype.

• ORAI2-Mediated Calcium Entry Drives Early Salivary Gland Fib

  2026-07-31

  This study identifies ORAI2-mediated store-operated calcium entry (SOCE) as a central mechanism in early-stage postirradiation fibrosis of salivary glands. By mapping the ORAI2/JNK/NFAT1/TGF-β1 axis and showing that pharmacological SOCE inhibition mitigates fibrogenesis and restores gland function, the research provides new molecular targets and workflow strategies for addressing radiation-induced hyposalivation.

• Moxidectin: Macrocyclic Lactone Anthelmintic for Antifungal

  2026-07-31

  Moxidectin, a macrocyclic lactone anthelmintic, is now proven to synergize with polyene antifungals by boosting ergosterol biosynthesis in Candida albicans, offering a powerful strategy for overcoming drug resistance and toxicity in oral candidiasis models. This article delivers actionable experimental workflows and troubleshooting tips for leveraging high-purity Moxidectin from APExBIO in advanced antifungal research.

• Fasudil (HA-1077) HCl: ROCK Inhibitor Workflows & Pitfalls

  2026-07-30

  Fasudil (HA-1077) HCl offers selective, reproducible ROCK pathway inhibition for precise studies of cell proliferation, migration, and apoptosis. This guide translates bench-proven protocols and advanced troubleshooting tips, empowering researchers to exploit Fasudil’s unique advantages—especially for cancer and hematological models.

• Paroxetine Mesylate Targets MET and ERBB3 in Colon Cancer Ce

  2026-07-30

  This study demonstrates that Paroxetine Mesylate, a selective serotonin reuptake inhibitor, exerts anticancer effects in human colorectal cancer cells by inhibiting receptor tyrosine kinases MET and ERBB3. These findings highlight drug repurposing potential and offer mechanistic insight into multi-targeted approaches for colorectal cancer.

• Fucoidan: Multi-Pathway Strategies for Translational Success

  2026-07-29

  Explore how Fucoidan, a sulfated α-L-Fucan from brown seaweed, is reshaping translational oncology and immunology. This thought-leadership article synthesizes advanced mechanistic insights—spanning apoptosis induction, immune modulation, and gut–liver axis repair—with strategic guidance for researchers. Moving beyond standard product pages, we detail experimental parameters and cross-domain opportunities, positioning APExBIO’s high-purity Fucoidan as an indispensable tool for next-generation studies.

• Docosahexaenoic Acid (DHA): Advanced Mechanisms in Neuroprot

  2026-07-29

  Explore how Docosahexaenoic Acid (DHA) drives neuroprotection by modulating hippocampal lipid metabolism and synaptic function. Discover unique mechanistic insights that inform advanced research protocols and distinguish this analysis from existing literature.

• S Tag Peptide (A6007): Technical Guidance for Fusion Tag Use

  2026-07-28

  S Tag Peptide (A6007) enables reliable protein solubility improvement, affinity purification, and antibody-based detection in recombinant protein workflows. It is best suited for aqueous protocols with validated anti-S-Tag reagents and should be avoided if ethanol solubility or long-term solution storage is required.

• Clozapine’s Neuropharmacology: Integrating ERK1/2 Activation

  2026-07-28

  Explore how Clozapine, a leading atypical antipsychotic medication, uniquely modulates ERK1/2 signaling and the EGF receptor in prefrontal neurons—bridging receptor pharmacology with emerging models of schizophrenia. This article provides advanced mechanistic insight and experimental guidance beyond standard protocols.

• SB-505124 Hydrochloride: Precision Tool for Fibrosis and Mec

  2026-07-27

  Discover how SB-505124 hydrochloride, a selective TGF-β/activin signaling inhibitor, advances fibrosis and mechanotransduction research with high specificity and favorable delivery. This article explores unique mechanistic and assay design insights not found elsewhere.

• Trichostatin A: Advanced Protocols for Epigenetic Regulation

  2026-07-27

  Unlock robust, reproducible epigenetic modulation with Trichostatin A (TSA) for oncology and differentiation workflows. Explore actionable protocols, troubleshooting insights, and the latest innovations bridging HDAC inhibition with real-time enzyme activity assays.

• Geneticin, G-418 Sulfate (SKU A2513): Reliable Selection and

  2026-07-26

  This article provides evidence-based guidance for using Geneticin, G-418 Sulfate (SKU A2513) to overcome common challenges in cell viability, selection, and antiviral assays. Integrating practical scenarios, literature data, and protocol optimization, we demonstrate how APExBIO's Geneticin enables reproducible, high-confidence results for biomedical research.

• Machine Learning Uncovers Novel Senolytics for Senescence Re

  2026-07-25

  The referenced study demonstrates how machine learning can efficiently identify new senolytic compounds by leveraging heterogeneous published datasets. This approach not only reduces screening costs but also expands the toolkit for targeting cellular senescence, with implications for cancer and age-associated disease research.

• Cepharanthine: Applied Workflows in Apoptosis and Disease Mo

  2026-07-24

  Cepharanthine, a biscoclaurine alkaloid, enables precise apoptosis modeling and immunomodulation in both cancer and endometriosis research. Its unique profile—validated in organoids and in vivo—translates to powerful experimental flexibility and clinical relevance.

• Ranolazine: Bridging Cardiac Metabolism and Translational In

  2026-07-24

  This thought-leadership article explores Ranolazine’s mechanistic role as an anti-ischemic agent, its impact on cardiac metabolism and relaxation, and its strategic value for translational researchers. Integrating recent advances in autophagy-innate immunity crosstalk and referencing both recent HBV mechanistic discoveries and advanced cardiac research workflows, this piece demonstrates how Ranolazine empowers novel experimental designs. It distinguishes itself by connecting metabolic modulation in cardiac ischemia with evolving research on cellular stress responses, providing actionable guidance and maturity-aware perspective for the translational research community.

15414 records 3/1028 page Previous Next 12345 下5页 Last page